03 - Navigating the Future of Pharmacy Benefit Costs: Trends, GLP-1, and Gene Therapy
This session will feature an in-depth analysis of pharmacy cost pressures with a focus on the impact of GLP-1 and Gene Therapy.
Speakers:
![](https://my.ccactuaries.org/portals/0/assets/images/contact/af901d2d-df51-4aa3-bab4-1a0158088f18.png)
Donna C. Novak
NovaRest Actuarial Consulting
Kali Schweitzer PharmD
Milliman Inc.
![](/ResourcePackages/Bootstrap4/assets/dist/css/images/img-speaker.jpg)
Mr. Ron Ogborne
Mercer
![](/ResourcePackages/Bootstrap4/assets/dist/css/images/img-speaker.jpg)
Ms. Sarah Suzanne Hellems
Optum Pharmacy Advisory Services